OpenVSafe by OpenVAERS
Search V-safe

339-82465-77482

4 vaccinations 11 coded responses 48 check-ins 9 free-text entries 1 call case
Sex
Male
Age at first dose
0-4
ZIP prefix
029 / RI
Registered
2022-07-08
Relationship
Child or adolescent in my care
Guardian
XGY-13209-28116
Race
White
Ethnicity
Not Hispanic or Latino

Possible VAERS report

VAERS IDConfidenceScoreRunner-upShared symptomsDose StateVAERS vaccinated / onset / receivedCall case
2603503 (opens in a new window) high 11 / 11 — 3 of 5 VAERS symptoms same dose (3) RI matches 2022-09-22 / 2023-01-30 / 2023-03-24
received the same day as the last call
 case 385847

From the VAERS matching of call center cases (loader/vaers_match_*). Only the best match is shown, and only if it scores 8 or more out of 11. The score adds up timing (VAERS received soon after the call center contact), dose and shared symptoms; state only breaks ties. Confidence is high when the score is 8+ and at least 3 points ahead of the runner-up, medium when 5+ and 2 ahead, otherwise low. A match is a likely link, not a confirmed one.

Timeline

  1. 2022-07-07
    Dose 1 — Pfizer-BioNTech
  2. 2022-07-08
    Registered in v-safe
  3. 2022-07-08
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  4. 2022-07-09
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  5. 2022-07-10
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  6. 2022-07-11
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  7. 2022-07-12
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  8. 2022-07-13
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  9. 2022-07-14
    Health check-in — day 7, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  10. 2022-07-21
    Survey response — day 14, dose 1, under 3
    MedDRA: Pyrexia — Feeling: Good · Be unable to work or attend school
    Free text: Fever
    MedDRA releases: 2024-11 · check-in free text available
  11. 2022-07-28
    Dose 2 — Pfizer-BioNTech
  12. 2022-07-28
    Health check-in — day 0, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  13. 2022-07-29
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  14. 2022-07-30
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  15. 2022-07-31
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  16. 2022-08-01
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  17. 2022-08-02
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  18. 2022-08-03
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  19. 2022-08-04
    Health check-in — day 7, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  20. 2022-08-11
    Health check-in — day 14, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  21. 2022-08-18
    Survey response — day 21, dose 2, under 3
    MedDRA: Fatigue, Rhinorrhoea — Feeling: Fair
    Free text: Runny nose, fatigue
    MedDRA releases: 2024-11 · check-in free text available
  22. 2022-08-25
    Health check-in — day 28, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  23. 2022-09-01
    Health check-in — day 35, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  24. 2022-09-08
    Health check-in — day 42, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  25. 2022-09-22
    Dose 3 — Pfizer-BioNTech
    Co-administered: Flu
  26. 2022-09-22
    Survey response — day 0, dose 3, under 3
    MedDRA: Cough — Feeling: Fair · Sleepiness · Be unable to work or attend school
    Free text: Cough
    MedDRA releases: 2024-11 · check-in free text available
  27. 2022-09-23
    Survey response — days 1–6 daily, dose 3, under 3
    MedDRA: Cough, Dysphonia, Rhinorrhoea — Feeling: Fair · Be unable to work or attend school
    Free text: Cough, hoarse voice, runny nose
    MedDRA releases: 2024-11 · check-in free text available
  28. 2022-09-24
    Survey response — days 1–6 daily, dose 3, under 3
    MedDRA: Cough, Dysphonia, Rhinorrhoea — Feeling: Fair
    Free text: Cough, runny nose, hoarse voice
    MedDRA releases: 2024-11 · check-in free text available
  29. 2022-09-25
    Survey response — days 1–6 daily, dose 3, under 3
    MedDRA: Productive cough — Feeling: Fair
    Free text: Productive cough
    MedDRA releases: 2024-11 · check-in free text available
  30. 2022-09-27
    Survey response — days 1–6 daily, dose 3, under 3
    MedDRA: Cough, Rhinorrhoea — Feeling: Good
    Free text: Runny nose, cough
    MedDRA releases: 2024-11 · check-in free text available
  31. 2022-09-28
    Health check-in — days 1–6 daily, dose 3, under 3
    Feeling: Good · None
    Under 3 check-in
  32. 2022-09-29
    Health check-in — day 7, dose 3, under 3
    Feeling: Good · None
    Under 3 check-in
  33. 2022-10-06
    Health check-in — day 14, dose 3, under 3
    Feeling: Good
    Under 3 check-in
  34. 2022-10-13
    Health check-in — day 21, dose 3, under 3
    Feeling: Good
    Under 3 check-in
  35. 2022-10-20
    Survey response — day 28, dose 3, under 3
    MedDRA: Productive cough, Respiratory tract congestion, Rhinorrhoea — Feeling: Good · Be unable to work or attend school
    Free text: Congestion/runny nose, productive cough
    MedDRA releases: 2024-11 · check-in free text available
  36. 2022-10-27
    Health check-in — day 35, dose 3, under 3
    Feeling: Good
    Under 3 check-in
  37. 2022-11-03
    Health check-in — day 42, dose 3, under 3
    Feeling: Good
    Under 3 check-in
  38. 2022-12-22
    Survey response — 3 months, dose 3, under 3
    MedDRA: Cough, Pyrexia — Feeling: Good · Be unable to work or attend school
    Free text: Fever, cough
    MedDRA releases: 2024-11 · check-in free text available
  39. 2023-03-23
    Survey response — 6 months, dose 3, under 3
    MedDRA: Cough, Ear infection, Rhinorrhoea — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    MedDRA releases: 2024-11
  40. 2023-03-23
    Report sent to call center — 6 months, dose 3, under 3
    Be unable to work or attend school · Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
  41. 2023-03-24
  42. 2023-03-24
  43. 2023-03-24
    Call successful
    Completed over the phone
  44. 2023-04-20
    Dose 4 — Pfizer-BioNTech
  45. 2023-04-20
    Health check-in — day 0, dose 4, under 3
    Feeling: Good · None
    Under 3 check-in
  46. 2023-04-21
    Health check-in — days 1–6 daily, dose 4, under 3
    Feeling: Good · None
    Under 3 check-in
  47. 2023-04-22
    Health check-in — days 1–6 daily, dose 4, under 3
    Feeling: Good · None
    Under 3 check-in
  48. 2023-04-23
    Health check-in — days 1–6 daily, dose 4, under 3
    Feeling: Good · None
    Under 3 check-in
  49. 2023-04-24
    Health check-in — days 1–6 daily, dose 4, under 3
    Feeling: Good · None
    Under 3 check-in
  50. 2023-04-25
    Health check-in — days 1–6 daily, dose 4, under 3
    Feeling: Good · None
    Under 3 check-in
  51. 2023-04-26
    Health check-in — days 1–6 daily, dose 4, under 3
    Feeling: Good · None
    Under 3 check-in
  52. 2023-04-27
    Health check-in — day 7, dose 4, under 3
    Feeling: Good · None
    Under 3 check-in
  53. 2023-05-04
    Health check-in — day 14, dose 4, under 3
    Feeling: Good
    Under 3 check-in
  54. 2023-05-11
    Health check-in — day 21, dose 4, under 3
    Feeling: Good
    Under 3 check-in
  55. 2023-05-18
    Health check-in — day 28, dose 4, under 3
    Feeling: Good
    Under 3 check-in
  56. 2023-05-25
    Health check-in — day 35, dose 4, under 3
    Feeling: Good
    Under 3 check-in
  57. 2023-06-01
    Survey response — day 42, dose 4, under 3
    MedDRA: Rhinorrhoea — Feeling: Good
    MedDRA releases: 2024-11

Vaccinations

DoseDateManufacturerCo-administered
12022-07-07Pfizer-BioNTech No
22022-07-28Pfizer-BioNTech No
32022-09-22Pfizer-BioNTech Flu
42023-04-20Pfizer-BioNTech No

Call center

ReportedOutcomeVAERS-related outcome
2023-03-23 Successful
2023-03-24
 Completed over the phone

Free text

Release 12 (Under 3) — day 14, dose 1, under 3

2022-07-21

Symptoms: Fever

Release 12 (Under 3) — day 21, dose 2, under 3

2022-08-18

Symptoms: Runny nose, fatigue

Release 12 (Under 3) — day 0, dose 3, under 3

2022-09-22

Systemic reaction (other): Cough

Release 12 (Under 3) — days 1–6 daily, dose 3, under 3

2022-09-23

Systemic reaction (other): Cough, hoarse voice, runny nose

2022-09-24

Systemic reaction (other): Cough, runny nose, hoarse voice

2022-09-25

Systemic reaction (other): Productive cough

2022-09-27

Systemic reaction (other): Runny nose, cough

Release 12 (Under 3) — day 28, dose 3, under 3

2022-10-20

Symptoms: Congestion/runny nose, productive cough

Release 12 (Under 3) — 3 months, dose 3, under 3

2022-12-22

Symptoms: Fever, cough

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCough · · ✓
SDEar infection · · ✓
SDFatigue · · ✓
SDProductive cough · · ✓
SDPyrexia · · ✓
SDRespiratory tract congestion · · ✓
SDRhinorrhoea · · ✓
SROCough · · ✓
SRODysphonia · · ✓
SROProductive cough · · ✓
SRORhinorrhoea · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…